Pharmacotherapy of Parkinson disease dementia and Lewy body dementia.
The pharmacotherapy of Parkinson disease dementia and Lewy body dementia with cholinesterase inhibitors and selected psychotropic drugs is relatively new. Review of literature supplemented by expert opinion. Cholinesterase inhibitors can be used by primary care practitioners and specialists, with often clinically meaningful results. Primary care practitioners play an essential role in the diagnosis and management of patients with these conditions.
Gauthier
Serge
S
D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D020961:Lewy Body Disease / Q000188:drug therapy*; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy*
D002800:Cholinesterase Inhibitors